Hoth Therapeutics

Hoth Therapeutics is a clinical-stage biopharmaceutical company focused on developing next-generation therapies for unmet medical needs. Hoth's pipeline development focuses on improving the quality of life for patients with indications such as atopic dermatitis, cancer treatment-related skin toxicity, chronic wounds, psoriasis, asthma, acne, and pneumonia. Hoth has also signed two separate agreements to further develop two therapeutic prospects for the prevention or treatment of COVID-19.